Cargando…

Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment

OBJECTIVE: The acute-on-chronic liver failure associated with hepatitis B virus (HBV-ACLF) was a type of clinical syndrome with rapid deterioration of liver function. It was characterized by short-term elevated bilirubin, ascites, prolonged clotting time, hepatic encephalopathy, organ failures, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Wenhan, Liao, Wei, Luo, Yiping, You, Benming, Yu, Jiao, Li, Chengzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712409/ https://www.ncbi.nlm.nih.gov/pubmed/33336028 http://dx.doi.org/10.1515/med-2020-0207

Ejemplares similares

Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure
por: Qu, Feng, et al.
Publicado: (2014)

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study
por: Li, Peng, et al.
Publicado: (2022)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure
por: Wang, Feixia, et al.
Publicado: (2021)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Sun, Yunqing, et al.
Publicado: (2022)

Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure
por: Lei, Ziying, et al.
Publicado: (2015)

Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure
por: Lin, Lin, et al.
Publicado: (2022)

IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation
por: Pang, Xiuqing, et al.
Publicado: (2018)

A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure
por: Luo, Yue, et al.
Publicado: (2016)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
por: Wang, Tongyu, et al.
Publicado: (2022)

Testosterone and Estradiol as Novel Prognostic Indicators for HBV-Related Acute-on-Chronic Liver Failure
por: Sun, Shuning, et al.
Publicado: (2021)

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure
por: Wang, Ke, et al.
Publicado: (2021)

Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Lili, et al.
Publicado: (2022)

Prealbumin as a Predictor of Short-Term Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Zhang, Hao, et al.
Publicado: (2023)

Establishment of a new acute-on-chronic liver failure model
por: Li, Fangfang, et al.
Publicado: (2017)

Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure
por: Chen, Jun-feng, et al.
Publicado: (2021)

Artificial Liver Support System Improves Short- and Long-Term Outcomes of Patients With HBV-Associated Acute-on-Chronic Liver Failure: A Single-Center Experience
por: Qin, Gang, et al.
Publicado: (2014)

Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure
por: Yao, Naijuan, et al.
Publicado: (2022)

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
por: Li, Peng, et al.
Publicado: (2021)

Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Song, Zhiying, et al.
Publicado: (2023)

Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment
por: Ju, Tao, et al.
Publicado: (2023)

Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure
por: Wan, Zhihong, et al.
Publicado: (2015)

The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis
por: Yang, Jiao, et al.
Publicado: (2016)

HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis
por: Liu, Xiaohui, et al.
Publicado: (2021)

A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure
por: Sun, Jian, et al.
Publicado: (2021)

Predictive value of elevated serum D-dimer for short-term prognosis in patients with HBV-related acute-on-chronic liver failure
por: Cao, Qianmei, et al.
Publicado: (2022)

Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome
por: Chen, Liwen, et al.
Publicado: (2020)

A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study
por: Qiang, Li, et al.
Publicado: (2020)

Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure
por: Cai, Junjun, et al.
Publicado: (2018)

Copy number gain of pro-inflammatory genes in patients with HBV-related acute-on-chronic liver failure
por: Sun, Fengming, et al.
Publicado: (2020)

Landscapes of gut microbiome and bile acid signatures and their interaction in HBV-associated acute-on-chronic liver failure
por: Bao, Zhiwei, et al.
Publicado: (2023)

The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure
por: Zhang, Xiangying, et al.
Publicado: (2019)

Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis
por: Xiao, Lan-Lan, et al.
Publicado: (2019)

CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure
por: Li, Yuxin, et al.
Publicado: (2021)

Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression
por: Liu, Guofeng, et al.
Publicado: (2022)

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
por: Xu, Huan, et al.
Publicado: (2012)

Characteristics and risk factors of infections in patients with HBV-related acute-on-chronic liver failure: a retrospective study
por: Zhang, Qian, et al.
Publicado: (2022)

The progress to establish optimal animal models for the study of acute-on-chronic liver failure
por: Zhai, Hengben, et al.
Publicado: (2023)

Clinical and Virological Aspects of HBV Reactivation: A Focus on Acute Liver Failure
por: Anastasiou, Olympia E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_21ntl5nnp6npmkcfqjijl6ac71